Large Spectral Shift of Mn2+ Emission Due to the Shrinkage of the Crystalline Host Lattice of the Hexagonal CsCdCl3 Crystals and Phase Transition.

All-inorganic halide perovskite crystals are considered excellent optical host lattices for various dopants to obtain wavelength-tunable emissions with ultra-broad bands even over a wide spectral range. Here, a series of Mn2+-doped bulk ligand-free CsCdCl3 (CCC) perovskite crystals with a hexagonal shape and size of about 1 millimeter (mm) have been prepared by a facile hydrothermal method. These CCC:Mn2+ (CCC:Mn) crystals emit the representative orange-red photoluminescence (PL) of Mn2+ (4T1(G)-6A1(S)) in the centers of hexagonal octahedrons coordinated with six Cl- ions. A fine-tuning of the Mn2+ concentration from 1 to 50 mol % Cd2+ induces a substantial red shift of emission spectra from 570 to 630 nm due to the shrinkage of the crystalline host lattice, and the maximum intensity of emission is achieved at 20 mol % Mn2+ doping. A further increase in the Mn2+ concentration causes a decrease of the PL intensity due to the phase transition from CCC to CsMnCl3·2H2O (CMCH). The strong excitation bands at 360, 370, 420, and 440 nm can make the excitation of the emissive CCC:Mn crystals possible with ultraviolet (UV) and blue chips for application in white light-emitting diodes (WLEDs). The similarity of the Mn2+-concentration-dependent emission spectra excited by various wavelengths indicates that there is only one type of site for Mn2+ occupation in CCC.

Polysaccharides from Nostoc commune Vaucher activate macrophages via NF-κB and AKT/JNK1/2 pathways to suppress colorectal cancer growth in vivo.

Colorectal carcinoma (CRC) is an aggressive malignancy with very limited therapeutic options. As a result, both morbidity and mortality of this malignancy are very high. It is well-established that Nostoc commune Vaucher is a type of healthy food and has been used as a traditional medicine against human cancers. However, the underlying mechanism(s) by which Nostoc commune Vaucher inhibits CRC was never described. Here we reported that polysaccharides from Nostoc commune Vaucher are a potent inhibitor of CRC growth by activating macrophages. Specifically, we purified polysaccharides from Nostoc commune and two fractions of these polysaccharides are able to inhibit the proliferation and growth of five human CRC cell lines with divergent genetic backgrounds. Through activating NF-κB and AKT/JNK1/2 signaling pathways, one fraction of polysaccharides significantly activated macrophages, which was reflected by the enlarged size of macrophages, enhanced phagocytosis and expression of TNF-α and IL-1ß. In summary, this study demonstrated that the polysaccharides from Nostoc commune Vaucher are a potent activator of macrophages, which subsequently contributes to the inhibition of CRC.